Related Experiment Video
Updated: Jun 24, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
Novel therapies for atopic eczema
1Universitätsklinikum Charité Klinik for Dermatologie, Venerologie und Allergologie, Schumannstr 20-21, 10117 Berlin, Germany. margitta.worm@charite.de
Current Opinion in Investigational Drugs (London, England : 2000)
|December 13, 2002
Summary
Topical treatments for atopic dermatitis (AD) are evolving beyond glucocorticosteroids. New immune modulators and compounds targeting skin barrier function offer promising therapeutic avenues for eczema management.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Atopic dermatitis (AD) management has historically relied on topical glucocorticosteroids.
- Recent advancements include topical immune modulators like tacrolimus and pimecrolimus.
- Growing understanding of AD's pathophysiology reveals new therapeutic targets.
Purpose of the Study:
- To review current and emerging therapeutic approaches for atopic dermatitis.
- To discuss novel compounds and treatment strategies based on recent literature and patents.
- To explore treatments targeting immune dysregulation and skin barrier defects in AD.
Main Methods:
- Comprehensive literature review of pathophysiological interactions and immunological disturbances in AD.
- Analysis of research findings and recent patents related to AD treatments.
- Critical discussion of various therapeutic agents, including glucocorticoid derivatives, immune modulators, and complementary therapies.
Main Results:
- Glucocorticoid family members (retinoids, vitamin D, PPAR agonists) show differentiating, antiproliferative, and immunomodulatory effects.
- Anti-infective, antipruritic agents, and skin barrier enhancers are presented as treatment options.
- Phytopharmacological approaches and patented experimental compounds targeting immune pathways are discussed.
Conclusions:
- The treatment landscape for atopic dermatitis is expanding with novel immunomodulators and targeted therapies.
- Compounds influencing skin barrier function and immune responses hold significant therapeutic potential for AD.
- Future treatments may involve a combination of established and innovative agents, including patented experimental compounds.
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...